e+CancerCare announces major partnership with OncoLogics

e+CancerCare, a leading operator of outpatient cancer care centers that combines clinical and service expertise to better manage patients, today announced a major partnership with OncoLogics, Inc., a Lafayette-based radiation oncology group. The partnership represents e+CancerCare's entry into the Louisiana and Mississippi markets and adds eight locations to e+CancerCare's portfolio of 16 outpatient community cancer care centers in Wyoming, Florida, Colorado, Oklahoma, Texas and Georgia. OncoLogics is the only American College of Radiation Oncology (ACRO) accredited facility in the state of Louisiana.

"OncoLogics is widely recognized as the most comprehensive radiation oncology provider in the region, and is well-known in the community as an education resource," said Amy Radcliff, president and chief operating officer at e+CancerCare. "At e+CancerCare, we believe in a patient centric approach, collaborating with local providers in order to deliver the best cancer care in the community. Our partnership with OncoLogics offers patients the most complete cancer therapy option built on our deep understanding of coordinated clinical care with world class service."

e+CancerCare's partnership will help to expand services, treatments and technologies at each of OncoLogics eight centers in the region. OncoLogics patients will also have access to the e+CancerCare CancerHome™ program, a formalized approach to care that surrounds patients with support tools from nutrition and financial counseling to collaboration around clinical care.

"When it comes to treating cancer, we strongly believe that close proximity to your local support system plays a critical role in both treatment and recovery," said M. Maitland DeLand, M.D., president, CEO and owner of OncoLogics. "It's clear that the e+CancerCare team is culturally aligned with our philosophy of providing quality cancer care close to home. This partnership is a natural extension of our commitment to increase access to the most personalized and advanced treatment modalities and support services."